APPLICATIONS PUBLISHED 3 SEPTEMBER 2003
Published: 1-Feb-2004
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
Particulate inhalation carrier
School of Pharmacy, University of London 1339388*
Compsns for sustained delivery of hydrophobic drugs and process for the preparation thereof
Samyang 1339389*
Synthesis of small particles
Unisearch 1339390*
Solid unsaturated fatty acid compsns
SLA Pharma 1339391*
Method and preparation for binding acetaldehyde in saliva, stomach and large intestine
Biohit 1339394*
Edible PGA (propylene glycol alginate) coating compsn
FMC Corp 1339395*
Magnetic particles for the targeted regional therapy
Alexiou, Christoph; Bergemann, Christian 1339396*
Absorbing agents and cover layer which is impermeable to active substances and which contains channel-formers or removable protective layer of a transdermal therapeutic system
Hexal 1338397*
Treatment of motor fluctuations with 5-hydroxytryptamine 1A receptor activity enhancing compounds
Motac Neuroscience 1339398*
Combinations of drugs (e.g. chloropromzine and pentamidine) for the treatment of neoplastic disorders
Combinatorx 1339399*
Hydroxamic acid or N-formyl hydroxylamine derivatives as inhibitors of bacterial polypeptide derformylase for treating microbial infections
British Biotech Pharmaceuticals 1339400*
Stenoprophilic matrices, and methods of making and using the same
Guritza, Dennis A 1339401
Benzoazapine and benzodiazepine derivatives and their use as PARP inhibitors
Guildford Pharmaceuticals 1339402*
Repinotan kit
Bayer 1339403*
Compsn and method
Colgate-Palmolive 1339404*
Use of anti-muscarinic agents and calcium channel blockers in combination
Arakis 1339405*
Piperazine derivatives, their preparation and their use of treating central nervous system (CNS) disorders
Wyeth 1339406*
Farnesyl protein transferase inhibitors for the treatment of inflammatory bowel disease
Janssen Pharmaceutica 1339407*
Drug formulation having improved oral tolerability
Procter & Gamble 1339408*
Use of rosuvastatin (ZD-4522) in the treatment of heterozygous familial hypercholesterolemia
AstraZeneca 1339409*
Use of pyrazolo 4,3-D]pyrimidines
Merck 1339410*
Use of bisphosphonates for pain treatment
Novartis 1339411*
Formulation containing phosphate derivatives of electron transfer agents
Vital Health Sciences 1339412*
Complexes of phosphate derivatives
Vital Health Sciences 1339413*
L-histidine in ophthalmic solutions
Bio-Concept Laboratories 1339414*
The compsn of multipurpose high functional alkaline solution compsn, preparation thereof, and for the use of a nonspecific immunostimulator
Baradon-S. F. Corp 1339415*
Trace elements
Warburton Technology 1339416*
Preparation for the treatment of surface open wounds
Stiftung fuer Plastische und Aesthethische Wundheilung im Sondervermoegen der DT Deutschen Stiftungsteuhend 1339417*
Improved ophthalmic and contact lens solutions containing simple saccharides as preservative enhancers
Bio-Concept Laboratories 1339418*
Use of active agent against candida in the treatment of disorders of the oral and intestina mucosa
Proge Farm 1339419*
Process for preparing aqueous extracts of plants and extracts so obtained
Bomsund Grupo Asesor 1339420*
Cosmetic and/or dermapharmaceutical preparations containing native proteins for the pant Argania spinosa
Cognis France 1339421*
Histaminase of vegetable origin for use in the treatment of allergic and septic shock and of allergic asthma
Universita' degli Studi di Roma "La Sapienza:' Universita' degli Studi' Roma Tre'; Universite du Quebec àMontreal 1339422*
Intraflagellar transport
University of Massachusetts 1339423*
Modulations of preicyte proliferation use BPI protein products of BPI inhibitors
XOMA Technology 1339424*
Vaccine compsn containing transforming growth factor alpha
Centro de Immunologia Molecular 1339425*
Antibodies that immunospecifically bind to trail receptors
Human Genome Sciences 1339426*
Method of producing biospecific molecules by protein trans-splicing
Elusys Therapeutics 1339427*
Inhalation of nitric oxide
Aga 1339428*
Compsn containing statins and calcium for improved cardiovascular health
SmithKline Beecham 1339429*
Freeze-dried pantoprazole preparation and pantoprazole injection
Byk Gulden Lomberg Chemische Fabrik 1339430*
Improved oral delivery of peptides using enzyme-cleavable membrane translocators
Unigene Laboratories 1339431*
Molecular inclusion compounds consisting of biocatalytically obtained, linear, water-insoluble polysaccharides, and of fatty acids and their derivatives
Celanese Ventures 1339432*
Expression of keratin genes 8 and 18 for treating tumours, in particular a mammary carcinoma
Schaller, Gerhard 1339433*
